VAN NAARDEN JACOB (Chief Business Officer) sold 42.2% of their position (10K shares) of LOXO ONCOLOGY, INC. on the open market
Open‑market sale worth $1.65M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5.50K
Price / share
$3.65
Trade value
$20.06K
% of position
Common Stock
Shares
−2K
Price / share
$165.13
Trade value
$330.26K
% of position
Common Stock
Shares
−400.00
Price / share
$165.88
Trade value
$66.35K
% of position
Common Stock
Shares
−500.00
Price / share
$167.19
Trade value
$83.60K
% of position
Common Stock
Shares
−2.30K
Price / share
$168.85
Trade value
$388.35K
% of position
Common Stock
Shares
−300.00
Price / share
$169.40
Trade value
$50.82K
% of position
Common Stock
Shares
+4.50K
Price / share
$3.65
Trade value
$16.42K
% of position
Common Stock
Shares
−600.00
Price / share
$160.62
Trade value
$96.37K
% of position
Common Stock
Shares
−1.10K
Price / share
$161.52
Trade value
$177.67K
% of position
Common Stock
Shares
−1.19K
Price / share
$162.70
Trade value
$194.26K
% of position
Common Stock
Shares
−1.01K
Price / share
$163.78
Trade value
$164.77K
% of position
Common Stock
Shares
−600.00
Price / share
$164.68
Trade value
$98.81K
% of position
Net shares
+0.00
Net value
-$1.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2018 | M · Option Exercise | +5.50K | $3.65 | $20.06K | 40.1% | 13.70K | 19.20K |
| Common Stock Direct | 10/3/2018 | S · Sale | −2K | $165.13 | $330.26K | 10.4% | 19.20K | 17.20K |
| Common Stock Direct | 10/3/2018 | S · Sale | −400.00 | $165.88 | $66.35K | 2.3% | 17.20K | 16.80K |
| Common Stock Direct | 10/3/2018 | S · Sale | −500.00 | $167.19 | $83.60K | 3.0% | 16.80K | 16.30K |
| Common Stock Direct | 10/3/2018 | S · Sale | −2.30K | $168.85 | $388.35K | 14.1% | 16.30K | 14K |
| Common Stock Direct | 10/3/2018 | S · Sale | −300.00 | $169.40 | $50.82K | 2.1% | 14K | 13.70K |
| Common Stock Direct | 10/4/2018 | M · Option Exercise | +4.50K | $3.65 | $16.42K | 32.8% | 13.70K | 18.20K |
| Common Stock Direct | 10/4/2018 | S · Sale | −600.00 | $160.62 | $96.37K | 3.3% | 18.20K | 17.60K |
| Common Stock Direct | 10/4/2018 | S · Sale | −1.10K | $161.52 | $177.67K | 6.3% | 17.60K | 16.50K |
| Common Stock Direct | 10/4/2018 | S · Sale | −1.19K | $162.70 | $194.26K | 7.2% | 16.50K | 15.31K |
| Common Stock Direct | 10/4/2018 | S · Sale | −1.01K | $163.78 | $164.77K | 6.6% | 15.31K | 14.30K |
| Common Stock Direct | 10/4/2018 | S · Sale | −600.00 | $164.68 | $98.81K | 4.2% | 14.30K | 13.70K |
| Total | +0.00 | -$1.61M | ||||||
Employee Stock Option (Right to Buy)
Common Stock
4.50K shares
Shares
−4.50K
Strike price
3.648
Held after
48.27K
Exercisable
—
Employee Stock Option (Right to Buy)
Common Stock
5.50K shares
Shares
−5.50K
Strike price
3.648
Held after
52.77K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock4.50K shares | 10/4/2001 | M · Option Exercise | −4.50K | 3.648 | — | 48.27K |
| Employee Stock Option (Right to Buy) Direct | Common Stock5.50K shares | 10/3/2018 | M · Option Exercise | −5.50K | 3.648 | — | 52.77K |